ALSO NOTED: Ortec raises cash; ConjuChem sells tax loss; and much more...

Email LinkedIn
Tools

> Ortec International has arranged a private placement of $6 million in shares, paving the way for its merger with Hapto Bipotech. Release

> With its stock price in the tank, ConjuChem sold $100 million in tax loss carry forwards for $6.4 million. Report

> Abbott Molecular has obtained the license to several of Affymetrix's patents. Release

> Alfrase Pharma has inked a deal with Tanabe Seiyaku to develop Modafinil. Report

> Threshold Pharmaceuticals has completed enrollment in its Phase III clinical trial evaluating TH-070 for the potential treatment of benign prostatic hyperplasia. Release

And Finally… Researchers say that going hungry-without starving--may be the closest thing we'll find to a fountain of youth. Article